Association of TCF7L2 Variants in Type 2 Diabetes Mellitus with Hypertriglyceridemia - A Case-Control Study

Overview

Journal Indian J Endocrinol Metab

Specialty Endocrinology

Date 2023 Oct 23

PMID 37867984

Authors

Nagarajan Gunavathy

Ramanathan Balaji

Velayutham Kumaravel

Affiliations

Soon will be listed here.

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic condition involving various genetic and environmental factors leading to impaired insulin secretion, resulting in hyperglycemia. The transcription factor 7-like 2 (TCF7L2) gene is an element of the Wnt signaling pathway that plays an important role in glucose and lipid metabolism. The aim of this study is to evaluate the association of TCF7L2 rs7903146 and rs12255372 polymorphisms in T2DM with hypertriglyceridemia.

Methods: We investigated the effect of rs7903146 and rs12255372 on T2DM with high triglyceride (TG) levels in 60 patients and 20 controls. The anthropometric measurements and biochemical tests were assessed. Peripheral blood samples were collected, and genomic DNA was extracted. The genotyping of TCF7L2 polymorphisms was carried out using polymerase chain reaction (PCR)-based direct sequencing and allele-specific PCR methods. The T2DM patients and controls were compared by means of the t-test, Chi-square test, odds ratio (OR), and 95% confidence interval (CI) using .

Results: The HbA1c was found to be 9.7 ± 2.1 and 5.4 ± 0.5% in patients and controls, respectively. The average TG levels ( < 0.005) in patients were 205.2 ± 145.7 and 106.4 ± 27.4mg/dl in controls. Significant evidence of association was found in T2DM patients having high TG levels with rs7903146 CT/TT (OR: 4.89; = 0.0105) and rs12255372 GT/TT (OR: 5.23; = 0.0101) genotypes when compared to controls.

Conclusion: The results of this study show that TCF7L2 rs7903146 CT/TT and rs12255372 GT/TT genotypes are significantly associated with the risk of hypertriglyceridemia in individuals with T2DM among the studied population.

References

Sanghera D, Nath S, Ortega L, Gambarelli M, Kim-Howard X, Singh J . TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels. Ann Hum Genet. 2008; 72(Pt 4):499-509. DOI: 10.1111/j.1469-1809.2008.00443.x. View

Mondal A, Das S, Baldini G, Chu W, Sharma N, Hackney O . Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans. J Clin Endocrinol Metab. 2010; 95(3):1450-7. PMC: 2841530. DOI: 10.1210/jc.2009-2064. View

Jin T . Current Understanding on Role of the Wnt Signaling Pathway Effector TCF7L2 in Glucose Homeostasis. Endocr Rev. 2016; 37(3):254-77. DOI: 10.1210/er.2015-1146. View

Pearson E, Donnelly L, Kimber C, Whitley A, Doney A, McCarthy M . Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes. 2007; 56(8):2178-82. DOI: 10.2337/db07-0440. View

Perez-Martinez P, Perez-Caballero A, Garcia-Rios A, Yubero-Serrano E, Camargo A, Gomez-Luna M . Effects of rs7903146 variation in the Tcf7l2 gene in the lipid metabolism of three different populations. PLoS One. 2012; 7(8):e43390. PMC: 3423356. DOI: 10.1371/journal.pone.0043390. View

Wrzosek M, Sawicka A, Wrzosek M, Piatkiewicz P, Talalaj M, Nowicka G . Age at onset of obesity, transcription factor 7-like 2 (TCF7L2) rs7903146 polymorphism, adiponectin levels and the risk of type 2 diabetes in obese patients. Arch Med Sci. 2019; 15(2):321-329. PMC: 6425208. DOI: 10.5114/aoms.2017.69638. View

Sarwar N, Gao P, Kondapally Seshasai S, Gobin R, Kaptoge S, Di Angelantonio E . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. PMC: 2904878. DOI: 10.1016/S0140-6736(10)60484-9. View

Duval A, Berger R, Hamelin R . Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet. 2000; 88(3-4):264-5. DOI: 10.1159/000015534. View

Papadopoulou S, Edlund H . Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes. 2005; 54(10):2844-51. DOI: 10.2337/diabetes.54.10.2844. View

10.

Assmann T, Duarte G, Rheinheimer J, Cruz L, Canani L, Crispim D . The TCF7L2 rs7903146 (C/T) polymorphism is associated with risk to type 2 diabetes mellitus in Southern-Brazil. Arq Bras Endocrinol Metabol. 2015; 58(9):918-25. DOI: 10.1590/0004-2730000003510. View

11.

Waeber B, Feihl F, Ruilope L . Diabetes and hypertension. Blood Press. 2002; 10(5-6):311-21. DOI: 10.1080/080370501753400610. View

12.

Helgason A, Palsson S, Thorleifsson G, Grant S, Emilsson V, Gunnarsdottir S . Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet. 2007; 39(2):218-25. DOI: 10.1038/ng1960. View

13.

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191-4. DOI: 10.1001/jama.2013.281053. View

14.

Huertas-Vazquez A, Plaisier C, Weissglas-Volkov D, Sinsheimer J, Canizales-Quinteros S, Cruz-Bautista I . TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia. Diabetologia. 2007; 51(1):62-9. DOI: 10.1007/s00125-007-0850-6. View

15.

Saxena R, Gianniny L, Burtt N, Lyssenko V, Giuducci C, Sjogren M . Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes. 2006; 55(10):2890-5. DOI: 10.2337/db06-0381. View

16.

Mahmoudi Alami F, Ahmadi M, Bazrafshan H, Tabarraei A, Khosravi A, Tabatabaiefar M . Association of the TCF7L2 rs12255372 (G/T) variant with type 2 diabetes mellitus in an Iranian population. Genet Mol Biol. 2012; 35(2):413-7. PMC: 3389527. DOI: 10.1590/S1415-47572012005000029. View

17.

Kondratyeva O, Sharafetdinov K, Plotnikova O, Pilipenko V, Alekseeva R, Sorokina E . [Clinical aspects of the effectiveness of metformin therapy in combination with a low-calorie diet in patients with type 2 diabetes mellitus with various variants of the gene polymorphism]. Vopr Pitan. 2022; 91(2):5-14. DOI: 10.33029/0042-8833-2022-91-2-5-14. View

18.

Nanfa D, Sobngwi E, Atogho-Tiedeu B, Noubiap J, Donfack O, Mofo E . Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study. Clin Transl Med. 2015; 4:17. PMC: 4434239. DOI: 10.1186/s40169-015-0058-1. View

19.

Alzahrani S, Baig M, Aashi M, Al-Shaibi F, Alqarni D, Bakhamees W . Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study. Diabetes Metab Syndr Obes. 2019; 12:1639-1644. PMC: 6718241. DOI: 10.2147/DMSO.S222271. View

20.

Bell S, Fletcher E, Brady I, Looker H, Levin D, Joss N . End-stage renal disease and survival in people with diabetes: a national database linkage study. QJM. 2014; 108(2):127-34. PMC: 4309927. DOI: 10.1093/qjmed/hcu170. View